<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03872011</url>
  </required_header>
  <id_info>
    <org_study_id>2019KY-145</org_study_id>
    <nct_id>NCT03872011</nct_id>
  </id_info>
  <brief_title>Vitamin C, Thiamine and Hydrocortisone for the Treatment of Septic Shock</brief_title>
  <official_title>Initiation of Vitamin C, Thiamine and Hydrocortisone Therapy for Septic Shock in Adults: A Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northern Jiangsu Province People's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Northern Jiangsu Province People's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether the combination therapy (vitamin C,thiamine
      and hydrocortisone) is effective in the treatment of septic shock.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Septic Shock is a leading cause of morbidity and mortality in critically ill patients
      worldwide.

      A potential benefit of vitamin C with thiamine and low-dose hydrocortisone in the treatment
      of septic shock has recently been described(PMID 27940189) . The patients with septic shock
      who received this combination of medications weaned off pressors earlier, suffered less organ
      failure, and had improved mortality. The doses of vitamin C used in this trial are high, yet
      seemed to be safe and can be considered for use.

      In this randomized controlled trial, we aim to evaluate the effect of the combination therapy
      (vitamin C,thiamine and hydrocortisone) on septic shock.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 19, 2019</start_date>
  <completion_date type="Anticipated">October 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2020</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>90-day mortality</measure>
    <time_frame>90 days after randomization</time_frame>
    <description>Death from any cause at 90 days after the onset of septic shock</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>ICU mortality</measure>
    <time_frame>90 days after randomization</time_frame>
    <description>All-cause mortality at ICU discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital mortality</measure>
    <time_frame>90 days after randomization</time_frame>
    <description>All-cause mortality at hospital discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>28-day mortality</measure>
    <time_frame>28 days after randomization</time_frame>
    <description>Death from any cause at 28 days after the onset of septic shock</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">406</enrollment>
  <condition>Septic Shock</condition>
  <arm_group>
    <arm_group_label>Vitamin C,thiamine,hydrocortisone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The combination of vitamin C, thiamine, hydrocortisone :
Vitamin C 2g every 6 hours x 5-days Thiamine 200mg every 12 hours x 5-days Hydrocortisone 200mg as a continuous infusion x 5-days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Normal Saline Solution (0.9%NaCl) in a volume to match all experimental arm components</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vitamin C,thiamine,hydrocortisone</intervention_name>
    <description>Vitamin C (2g) will be diluted in 100ml 0.9%NACL and administered ivd every 6 hours for 5 days or until participant is discharged from the ICU.
Thiamine(200mg) will be diluted in 100ml 0.9%NACL and administered ivd every 12 hours for 5 days or until participant is discharged from the ICU. Hydrocortisone was administered 200 mg/d as a continuous infusion for 5 days or until participant is discharged from the ICU.</description>
    <arm_group_label>Vitamin C,thiamine,hydrocortisone</arm_group_label>
    <other_name>Ascorbic Acid</other_name>
    <other_name>Vitamin B1</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Normal saline (0.9% NaCl solution) volume to match all components</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Normal saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 years old or older

          -  Onset of septic shock within 12 hours

        Exclusion Criteria:

          -  Systemic corticosteroid therapy within the last 3 months before septic shock

          -  High-dose steroid therapy

          -  Immunosuppression

          -  Pregnant

          -  Known glucose-6 phosphate dehydrogenase (G-6PD) deficiency

          -  Known hemachromatosis

          -  Known allergy to vitamin C, hydrocortisone, or thiamine

          -  Anticipated death from a preexisting disease within 90 days after randomization (as
             determined by the enrolling physician)

          -  Refusal of the attending staff or patient family
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Qingquan Lyu, Master</last_name>
    <role>Principal Investigator</role>
    <affiliation>Northern Jiangsu Province People's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Qingquan Lyu, Master</last_name>
    <phone>0086-18051063899</phone>
    <email>bonhomie2014@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Xiaohua Gu, Master</last_name>
    <phone>0086-18051062325</phone>
    <email>njguxiaohua@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Northern Jiangsu Province people's hospital</name>
      <address>
        <city>Yangzhou</city>
        <state>Jiangsu</state>
        <zip>225000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Qingquan Lyu, Master</last_name>
      <phone>0086-18051063899</phone>
      <email>bonhomie2014@163.com</email>
    </contact>
    <contact_backup>
      <last_name>Xiaohua Gu, Master</last_name>
      <phone>0086-18051062325</phone>
      <email>njguxiaohua@163.com</email>
    </contact_backup>
    <investigator>
      <last_name>Qingquan Lyu, Master</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Xiaohua Gu, Master</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ruiqiang Zheng, Bachelor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Qihong Chen, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fengdi Yan, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jiangquan Yu, Master</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>March 4, 2019</study_first_submitted>
  <study_first_submitted_qc>March 9, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 12, 2019</study_first_posted>
  <last_update_submitted>May 2, 2020</last_update_submitted>
  <last_update_submitted_qc>May 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Northern Jiangsu Province People's Hospital</investigator_affiliation>
    <investigator_full_name>Qing-quan Lv</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>septic shock</keyword>
  <keyword>vitamin C</keyword>
  <keyword>thiamine</keyword>
  <keyword>hydrocortisone</keyword>
  <keyword>mortality</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Shock, Septic</mesh_term>
    <mesh_term>Shock</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Ascorbic Acid</mesh_term>
    <mesh_term>Thiamine</mesh_term>
    <mesh_term>Hydrocortisone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

